@TOME V3
(Feb 2022)

Ref. - - Doc.
Global output mode :
Sort entries by :
Sequence Color type :

Show alignment :
Column output:
Score:

Alignment:

3D Common Core:

Structural Clustering:

Modeller Result :

Complexes Modeling
Templates Information:
Sequence & Result Tab:

Values color: [ Good | Correct | Middling | Bad ]Modeled complexes Tab: Displays ligands Score after transfer from template to model
Cell color: RMS between binding site of experimental template and receptor model: [‹ 3Å | ‹ 10Å | › 10Å]
Result: [ Good | Correct | Acceptable | Bad | Empty = ligand not selected during the calculation step or result rejected ]

Query sequence : VGFR2_HUMAN: (2019-05-28 )
MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV

Atome Classification :

(47 SA) Binding Score for complex ligand / Scwrl (Unconserved SChains Recalculated) model (Only selected ligand are displayed)
(Atome) (Ident) (Tito) (Num) (pKd) (Uniprot)

BAX_A_2(4ASD)

[Raw transfer]




BAX_A_2(3WZE)

[Raw transfer]




42Q_A_2(3VHE)

[Raw transfer]




5T2_A_3(5EW3)
VGFR2_HUMAN
[Raw transfer]




276_A_2(2QU5)

[Raw transfer]




F82_A_2(6GQO)

[Raw transfer]




03X_A_2(3U6J)

[Raw transfer]




LEV_A_2(3WZD)

[Raw transfer]




K11_A_2(3EWH)

[Raw transfer]




C92_B_4(3CPB)

[Raw transfer]




706_B_4(3EFL)

[Raw transfer]




03X_A_2(3U6J)

[Raw transfer]




0KF_A_2(3VO3)

[Raw transfer]




887_B_5(3B8R)

[Raw transfer]




C19_B_4(3CP9)

[Raw transfer]




608_C_3(2P2I)
VGFR2_HUMAN
[Raw transfer]




AXI_A_2(4AGC)

[Raw transfer]




608_D_4(2P2I)

[Raw transfer]




F88_A_2(6GQP)
?
[Raw transfer]




C92_A_3(3CPB)
VGFR2_HUMAN
[Raw transfer]




5T2_B_4(5EW3)

[Raw transfer]




900_B_4(3B8Q)

[Raw transfer]




857_B_5(2QU6)

[Raw transfer]




AAX_B_2(1Y6B)

[Raw transfer]




706_A_3(3EFL)
VGFR2_HUMAN
[Raw transfer]




2RL_A_2(2RL5)

[Raw transfer]




AV9_A_2(4ASE)

[Raw transfer]




8ST_A_2(3HNG)

[Raw transfer]




887_A_4(3B8R)
VGFR2_HUMAN
[Raw transfer]




0JA_A_2(3VNT)

[Raw transfer]




AXI_A_2(4AG8)

[Raw transfer]




AV9_A_2(4ASE)

[Raw transfer]




00J_A_2(2XIR)

[Raw transfer]




C19_A_3(3CP9)
VGFR2_HUMAN
[Raw transfer]




RAJ_A_2(3BE2)

[Raw transfer]




C52_B_4(3CPC)

[Raw transfer]




C52_A_3(3CPC)
VGFR2_HUMAN
[Raw transfer]




00J_A_2(2XIR)

[Raw transfer]




994_B_2(2P2H)

[Raw transfer]




F8B_A_2(6GQQ)

[Raw transfer]




900_A_3(3B8Q)
VGFR2_HUMAN
[Raw transfer]




KIM_A_4(3CJG)

[Raw transfer]




LIF_B_2(1YWN)

[Raw transfer]




A96_A_3(3DTW)
VGFR2_HUMAN
[Raw transfer]




BPK_A_2(3VHK)

[Raw transfer]




AAZ_A_2(1Y6A)

[Raw transfer]




B49_A_2(4AGD)

[Raw transfer]




69 HHSearch 92.9799%-141 - C6 -3U6J 11.9
64 HHSearch 92.11100%-137 - C6 -4ASE 9.9
70 HHSearch 91.42100%-143 - C6 -2XIR 9.7
6 PsiBlast_PDB 91.27100%-138 - C6 -3VHE 10.6
3 PsiBlast_PDB 90.4999%-133 - C6 -3VHK 7.0
24 Blastp_CBE 90.4385%-137 - C6 -3U6J 11.9
7 PsiBlast_PDB 90.2586%-145 - C6 -4AGC 9.5
10 PsiBlast_PDB 90.0286%-136 - C6 -4ASE 9.9
8 PsiBlast_PDB 89.7786%-146 - C6 -4AGD 7.5
9 PsiBlast_PDB 89.6786%-134 - C6 -4ASD 9.7
22 Blastp_CBE 89.6586%-140 - C6 -3WZE 10.3
11 PsiBlast_PDB 89.5786%-135 - C6 -3VNT 10.3
13 PsiBlast_PDB 89.0385%-130 - C6 -6GQO 11.0
12 PsiBlast_PDB 89.0386%-137 - C6 -3VO3 9.6
16 PsiBlast_PDB 89.0086%-143 - C6 -2XIR 9.7
14 PsiBlast_PDB 88.7285%-138 - C6 -6GQP 9.8 ?
15 PsiBlast_PDB 88.7085%-137 - C6 -6GQQ 9.8
44 Blastp_CBE 88.6185%-152 - C6 -2QU5 10.3
25 Blastp_CBE 88.4985%-141 - C6 -3EWH 11.1
17 PsiBlast_PDB 88.3686%-139 - C6 -4AG8 9.6
45 Blastp_CBE 88.0985%-155 - C6 -2P2H 7.2
23 Blastp_CBE 87.9086%-164 - C6 -3WZD 9.0
42 Blastp_CBE 87.6085%-147 - C6 -2RL5 10.2
39 Blastp_CBE 87.4685%-162 - C6 -3B8R 9.8 VGFR2_HUMAN
37 Blastp_CBE 87.3585%-149 - C6 -3BE2 11.4
36 Blastp_CBE 87.1985%-158 - C6 -3CP9 9.1 VGFR2_HUMAN
41 Blastp_CBE 87.0985%-153 - C6 -3B8Q 10.3 VGFR2_HUMAN
34 Blastp_CBE 87.0985%-164 - C6 -3CPB 7.6 VGFR2_HUMAN
5 PsiBlast_PDB 87.06100%-169 - C6 -1Y6B 8.8
32 Blastp_CBE 86.7185%-163 - C6 -3CPC 9.5 VGFR2_HUMAN
18 PsiBlast_PDB 86.5786%-157 - C6 -5EW3 9.3 VGFR2_HUMAN
29 Blastp_CBE 86.5185%-152 - C6 -2P2I 9.6 VGFR2_HUMAN
46 Blastp_CBE 85.7884%-158 - C6 -3CJG 6.7
30 Blastp_CBE 85.7185%-148 - C6 -3DTW 8.7 VGFR2_HUMAN
27 Blastp_CBE 85.5385%-149 - C6 -3EFL 8.8 VGFR2_HUMAN
4 PsiBlast_PDB 85.23100%-172 - C6 -1Y6A 7.1
28 Blastp_CBE 84.7585%-176 - C6 -2P2I 9.0
20 PsiBlast_PDB 84.7585%-152 - C6 -1YWN 9.7
40 Blastp_CBE 84.6685%-156 - C6 -3B8Q 10.6
38 Blastp_CBE 84.5285%-165 - C6 -3B8R 9.8
21 Blastp_CBE 84.3286%-163 - C6 -5EW3 9.3
43 Blastp_CBE 82.9485%-170 - C6 -2QU6 10.0
26 Blastp_CBE 82.7985%-169 - C6 -3EFL 8.4
35 Blastp_CBE 82.7785%-160 - C6 -3CP9 9.0
31 Blastp_CBE 82.4685%-165 - C6 -3CPC 9.6
47 Blastp_CBE 82.2573%-131 - C6 -3HNG 8.7
33 Blastp_CBE 81.2285%-164 - C6 -3CPB 7.8